SARS-CoV-2, Flu A/B + RSV
...A 44 – 100 (92.0−100) Influenza B 44 – 100 (92.0−100) RSV 44 – 100 (92.0−100) PBS SARS-CoV-2 204 87.6 (81.9–92.0) 100 (82.4−100) Influenza A 204 25.0 (0.6–80.6) 100 (98.2−100)... Read more
Search results for:Neueste TDA-C01 Pass Guide - neue Prüfung TDA-C01 braindumps - 100% Erfolgsquote 🧲 Suchen Sie jetzt auf ☀ www.itzert.com ️☀️ nach “ TDA-C01 ” und laden Sie es kostenlos herunter 🏨TDA-C01 German
Abacus Diagnostica, Kaivogen and Labrox are now together Uniogen
...Abacus Diagnostica +358 40 727 8690 erno.sundberg(at)abacusdiagnostica.com Leena Kokko CEO, Kaivogen +358 50 590 0853 leena.kokko(at)kaivogen.com Ida Erling Head of R&D, Labrox +358 50 372 3080 ida.erling(at)labrox.fi Uniogen in brief... Read more
Press release: Finnish diagnostics company Uniogen is developing a test for timely detection of ovarian cancer
...Team by appointing Tapani Elovirta (M.Sc.) as Commercial Director and Miro Marttila (M.Sc. (Econ.), M.Sc. (Tech.)) as CFO. Elovirta, who started in his new position in November, leads the company’s... Read more
HSV-1/2, VZV + EV
...virus WHO Fact sheet: Varicella, 4th of April 2015. Nikonov O.S. et al. (2017) Enteroviruses: Classification, Diseases They Cause, and Approaches to Development of Antiviral Drugs. Biochemistry (Mosc). 2017 Dec;82(13):1615-1631.... Read more
Letter of Intent signed with Kaivogen Oy to produce Lumito’s complete reagent kits
...production”. For further information, please contact: Lumito’s CEO, Mattias Lundin E-mail: ml@lumito.se phone: +46 76-868 45 09 Also, visit our website. Kaivogen, a Uniogen company, is a specialist in immunoassays... Read more
MRSA/SA AC
...95%) Specificity (%) (CI 95%) PPV (%) NPV (%) 232 100 (96.34–100) 100 (97.11 –100) 100 100 Ordering information To place an order, please contact your local distributor. Product name... Read more
MRSA/SA Multi Swab
...MRSA prevalence (%) Sensitivity (%) Specificity (%)* NPV (%) PPV (%) Long-term care facility and hospitalized patients; n = 83 53.0 100 61.1 100 75.9% At-risk patients on hospital admission;... Read more
SARS-CoV-2
...size, n PPA, % (CI 95%) NPA, % (CI 95%) Fresh 180 80.4 (66.1–90.6) 100 (97.3–100) Frozen 90 98.4 (91.3–100) 100 (87.7–100) Total 270 90.7 (83.6–95.5) 100 (97.8–100) Ordering information... Read more
SARS-CoV-2 2.0
...agreement. Specimen type Sample size, n PPA, % (CI 95%) NPA, % (CI 95%) Fresh 566 98.2 (94.7–99.6) 99.8 (98.6–100) Frozen 349 98.5 (95.5–99.7) 100 (97.7–100) Total 915 98.3 (96.4–99.4)... Read more
S. pneumoniae
...Dis 2005;5:83–93. Factsheet about pneumococcal disease; , 8/7/2022. Ostapchuk M, Roberts DM, Haddy R. Community-acquired pneumonia in infants and children. American family physician 2004; 70(5); 899-908. Todar 2002. Streptococcus pneumoniae:... Read more